According to a report from Reuters, AstraZeneca’s vaccine trial is to remain on hold in the United States until midweek, even though the company said it would be restarting. This comes as Pfizer CEO Bourla, claims that he is readying Pfizer for the end of year as he believes the U.S. government will make a push to make a vaccine publicly available. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.
